Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retroperitoneal sarcomas

P C McGrath1

  • 1Department of Surgery, University of Kentucky Chandler Medical Center, Lexington 40536-0084.

Seminars in Surgical Oncology
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Retroperitoneal sarcomas are rare tumors. Aggressive surgery is key for survival, but local recurrence remains a challenge, necessitating careful patient monitoring and further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

The New England journal of medicine·2002
Same author

Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.

Cancer·2000
Same author

A multidimensional approach to breast cancer education.

Journal of cancer education : the official journal of the American Association for Cancer Education·2000
Same author

Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response.

International journal of radiation oncology, biology, physics·2000
Same author

Stability and change in posttraumatic stress disorder symptoms following breast cancer treatment: a 1-year follow-up.

Psycho-oncology·2000
Same author

Rheumatoid symptoms following breast cancer treatment: a controlled comparison.

Journal of pain and symptom management·1999
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Area of Science:

  • Surgical Oncology
  • Medical Oncology
  • Pathology

Background:

  • Retroperitoneal sarcomas are uncommon malignancies, representing 10-20% of soft tissue sarcomas.
  • Their deep location and slow growth lead to late detection, often at advanced stages.
  • Current early detection rates offer limited improvement potential.

Purpose of the Study:

  • To review the challenges in managing retroperitoneal sarcomas.
  • To emphasize the importance of aggressive surgical resection for improved outcomes.
  • To discuss the limitations of current adjuvant therapies and the need for further research.

Main Methods:

  • Review of existing literature on retroperitoneal sarcomas.
  • Analysis of treatment strategies focusing on surgical resection and adjuvant therapies.

Related Experiment Videos

  • Discussion of challenges in local control and recurrence management.

    • Main Results:

    • Complete resection with negative margins is crucial for improving survival rates.
    • Resection often necessitates removal of adjacent organs and vascular structures.
    • Local recurrence remains a significant issue despite aggressive surgical approaches.

    Conclusions:

    • Aggressive surgical management is paramount for local control of retroperitoneal sarcomas.
    • Postoperative adjuvant therapies (irradiation/chemotherapy) have shown discouraging results.
    • Development of a national registry and intergroup studies is vital for advancing treatment strategies and improving survival rates.